![Christopher Paul Blackwell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher Paul Blackwell
Directeur/Membre du Conseil chez AGI Therapeutics Plc
Postes actifs de Christopher Paul Blackwell
Sociétés | Poste | Début | Fin |
---|---|---|---|
AGI Therapeutics Plc
![]() AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | Directeur/Membre du Conseil | 11/04/2007 | - |
Historique de carrière de Christopher Paul Blackwell
Anciens postes connus de Christopher Paul Blackwell
Sociétés | Poste | Début | Fin |
---|---|---|---|
NUFORMIX PLC | Directeur/Membre du Conseil | 10/05/2018 | - |
Président | - | 10/02/2021 | |
VECTURA GROUP | Directeur/Membre du Conseil | 01/10/2002 | 30/06/2015 |
Directeur Général | 01/02/2004 | 01/07/2015 | |
Directeur des opérations | 01/10/2002 | 01/02/2004 | |
Scotia Pharmaceuticals Ltd.
![]() Scotia Pharmaceuticals Ltd. Medical DistributorsDistribution Services Scotia Pharmaceuticals Ltd. engages in a pharmaceutical company. The company was founded on November 2, 1978 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 01/01/1998 | - |
Corporate Officer/Principal | 15/09/2010 | - | |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01/01/1996 | - |
GlaxoSmithKline Research & Development Ltd.
![]() GlaxoSmithKline Research & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, GlaxoSmithKline Research & Development Ltd. is a British biopharma company that unites science, technology, and talent to get ahead of disease together. The company was founded in 1965 and is based in Brentford, UK. GSK's work in HIV is carried out entirely through ViiV Healthcare, which GSK majority owns with Pfizer and Shionogi as shareholders. The company is united to do better in various fields, from finance to communications, procurement to HR. GSK provides images and B-roll video for media use and has a privacy notice that applies to any individual who is a current or former registered shareholder of GSK plc. | Corporate Officer/Principal | 01/01/1988 | - |
Formation de Christopher Paul Blackwell
University of Bath | Doctorate Degree |
Statistiques
Internationale
Royaume-Uni | 6 |
Irlande | 2 |
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
NUFORMIX PLC | Health Technology |
Entreprise privées | 5 |
---|---|
Vectura Group Ltd.
![]() Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
AGI Therapeutics Plc
![]() AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | Health Technology |
GlaxoSmithKline Research & Development Ltd.
![]() GlaxoSmithKline Research & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, GlaxoSmithKline Research & Development Ltd. is a British biopharma company that unites science, technology, and talent to get ahead of disease together. The company was founded in 1965 and is based in Brentford, UK. GSK's work in HIV is carried out entirely through ViiV Healthcare, which GSK majority owns with Pfizer and Shionogi as shareholders. The company is united to do better in various fields, from finance to communications, procurement to HR. GSK provides images and B-roll video for media use and has a privacy notice that applies to any individual who is a current or former registered shareholder of GSK plc. | Commercial Services |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Scotia Pharmaceuticals Ltd.
![]() Scotia Pharmaceuticals Ltd. Medical DistributorsDistribution Services Scotia Pharmaceuticals Ltd. engages in a pharmaceutical company. The company was founded on November 2, 1978 and is headquartered in London, the United Kingdom. | Distribution Services |
- Bourse
- Insiders
- Christopher Paul Blackwell
- Expérience